Parnell Pharmaceuticals Holdings Ltd. announced consolidated earnings results for the year ended December 31, 2015. For the period, the company reported revenue of AUD 13,169,753 against AUD 8,361,058 a year ago. Loss before income tax was AUD 13,735,419 against AUD 11,362,506 a year ago. Loss for the year was AUD 13,737,532 against AUD 14,345,360 a year ago.

For the year 2016, the company expects total group revenue to grow 50% - 70% to AUD 20 million to AUD 22 million.